SCHEMBL6015597

SCHEMBL6015597

Cc1cc(-c2nnc(SCc3ccccn3)[nH]2)c(C)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.46
CYP2C9 P11712 7/20 0.46
CYP2E1 P05181 6/20 0.46
CYP2C8 P10632 6/20 0.46
CYP2D6 P10635 6/20 0.46
CYP2B6 P20813 6/20 0.46
CYP2C19 P33261 6/20 0.46
CYP3A4 P08684 6/20 0.46
LMNA P02545 4/20 0.44
ALDH1A1 P00352 3/20 0.44
PKM P14618 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KDM4E B2RXH2 2/20 0.43
GLA P06280 1/20 0.43
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MAPT P10636 2/20 0.40
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015591 0.81 CYP1A2 (0.46) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015599 0.80 CYP1A2 (0.56) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6002513 0.78 RAB9A (0.62) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015601 0.77 GLA (0.47) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015584 0.77 CYP1A2 (0.48) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015598 0.77 CYP1A2 (0.54) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015605 0.76 CYP1A2 (0.57) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015589 0.76 CYP1A2 (0.52) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL6015612 0.76 CYP1A2 (0.54) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6
SCHEMBL645267 0.76 RAB9A (0.63) CYP1A2CYP2C9CYP2E1CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054526-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed